Insiders · TARS

Michael Ackermann

Director at Tarsus Pharmaceuticals, Inc. (TARS)

Michael Ackermann has filed 11 insider reports with the SEC since June 2021, as director at Tarsus Pharmaceuticals, Inc. (TARS). Michael Ackermann made no open-market purchases or sales in the last 12 months. The latest filing, on July 1, 2022, reports grant or award at Tarsus Pharmaceuticals, Inc. (TARS).

Filings
11
Companies
1
Bought on market
$1.35M
Sold on market
$657K

Companies where Michael Ackermann is an insider

CompanyRoleShares heldBoughtSoldAvg buyPrice nowLast filing
Tarsus Pharmaceuticals, Inc. logo
TARS
Tarsus Pharmaceuticals, Inc.
Director1,208,273$1.35M$657K$13.50$73.01+441%Jul 1, 2022

Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record. Price now: the latest daily close, against the average buy price.

Every filing

Compare Michael Ackermann with

Other insiders at the same companies

Questions about Michael Ackermann

What is Michael Ackermann's role at Tarsus Pharmaceuticals, Inc.?
Michael Ackermann reports to the SEC as director at Tarsus Pharmaceuticals, Inc. (TARS), according to the latest filing on July 1, 2022.
How many shares does Michael Ackermann own?
After the latest filing that states it, Michael Ackermann directly owned 1,208,273 shares of Tarsus Pharmaceuticals, Inc. (TARS). Shares held through trusts, funds or family members are reported separately and are not counted here.
Has Michael Ackermann bought or sold stock recently?
The most recent open-market purchase was on May 5, 2022: bought 100,000 shares of Tarsus Pharmaceuticals, Inc. (TARS) for $1.35M at an average of $13.50. The most recent open-market sale was on December 1, 2021: sold 5,833 shares of Tarsus Pharmaceuticals, Inc. (TARS) for $144K at an average of $24.68.
How do I get alerts when Michael Ackermann files?
Follow Michael Ackermann on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.

From SEC Forms 3, 4, 5 and 144 filed by Michael Ackermann (SEC CIK 0001791249). Totals count each trade once, skipping amendments whose original is on file, from Jun 17, 2021 on. View on SEC EDGAR · Get this as JSON